Pharmacomicrobiomics and Drug Response

Abstract

Pharmacomicrobiomics is an emerging discipline that investigates the interplay between the human microbiome and drug response, emphasizing the influence of gut microbial composition on pharmacokinetics, pharmacodynamics, efficacy, and toxicity. Variations in the gut microbiota can significantly alter drug metabolism, leading to inter-individual differences in therapeutic outcomes. This review explores the current understanding of pharmacomicrobiomics, focusing on microbial-mediated drug metabolism, the bidirectional interaction between drugs and microbiota, the potential for personalized medicine, and the integration of multi-omics approaches. Analytical challenges, such as standardization of microbial profiling, functional annotation, and data integration, are discussed. Finally, the potential of microbiome-based interventions to optimize drug response and reduce adverse effects is highlighted.

KEYWORDS: Pharmacomicrobiomics, Gut Microbiota, Drug Response, Personalized Medicine, Pharmacokinetics, Pharmacodynamics, Microbial Drug Metabolism, Multi-Omics, Adverse Drug Reactions